A phase 1/2, randomized, placebo controlled and open label extension studies of Givosiran and investigational RNA interference therapeutic, in patients with acute intermittent porphyria

Authors:
  • ESE. Sardh
    E. Sardh
  • MBM. Balwani
    M. Balwani
  • PHP. Harper
    P. Harper
  • PSP. Stein
    P. Stein
  • DRD. Rees
    D. Rees
  • JBJ. Bloomer
    J. Bloomer
  • DBD.M. Bissell
    D.M. Bissell
  • CPC. Parket
    C. Parket
  • JPJ. Phillips
    J. Phillips
  • HBH. Bonkovsky
    H. Bonkovsky
  • RDR. Desnick
    R. Desnick
  • NAN. Al-Tawil
    N. Al-Tawil

Abstract
No abstract available